(Q43427754)

23 November 2017

Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder (English)

1 reference

23 November 2017

17

Kunitoshi Iseki

1 reference

23 November 2017

Masafumi Fukagawa

1

1 reference

23 November 2017

Keitaro Yokoyama

2

1 reference

23 November 2017

Fumihiko Koiwa

3

1 reference

23 November 2017

Masatomo Taniguchi

4

1 reference

23 November 2017

Tetsuo Shoji

5

1 reference

23 November 2017

Junichiro James Kazama

6

1 reference

23 November 2017

Hirotaka Komaba

7

1 reference

23 November 2017

Ryoichi Ando

8

1 reference

23 November 2017

Takatoshi Kakuta

9

1 reference

23 November 2017

Hideki Fujii

10

1 reference

23 November 2017

Msasaaki Nakayama

11

1 reference

23 November 2017

Yugo Shibagaki

12

1 reference

23 November 2017

Seiji Fukumoto

13

1 reference

23 November 2017

Naohiko Fujii

14

1 reference

23 November 2017

Motoshi Hattori

15

1 reference

23 November 2017

Akira Ashida

16

1 reference

23 November 2017

Takashi Shigematsu

18

1 reference

23 November 2017

Yusuke Tsukamoto

19

1 reference

23 November 2017

Yoshiharu Tsubakihara

20

1 reference

23 November 2017

Tadashi Tomo

21

1 reference

23 November 2017

Hideki Hirakata

22

1 reference

23 November 2017

Tadao Akizawa

23

1 reference

23 November 2017

CKD-MBD Guideline Working Group

24

1 reference

23 November 2017

Japanese Society for Dialysis Therapy

25

1 reference

23 November 2017

1 June 2013

1 reference

Therapeutic Apheresis and Dialysis

23 November 2017

1 reference

23 November 2017

17

1 reference

23 November 2017

247-288

1 reference

23 November 2017

3

1 reference

The kidney and bone metabolism: Nephrologists' point of view.

23 November 2017

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN1493 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Interpretation of serum calcium in patients with abnormal serum proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The impact of the assay for measuring albumin on corrected ('adjusted') calcium concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The influences of method of calcium correction and the timing of blood collection on application of the K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Inter-method variability in PTH measurement: implication for the care of CKD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mild hyperphosphatemia and mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Consistent control of mineral and bone disorder in incident hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of the time of administration of calcium acetate on phosphorus binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of activated vitamin D treatment and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Hypovitaminosis D in Medical Inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

High Prevalence of Vitamin D Inadequacy and Implications for Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

25-hydroxyvitamin D levels and the risk of mortality in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cinacalcet hydrochloride treatment significantly improves all-cause and cardiovascular survival in a large cohort of hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Phosphorus binders and survival on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Review of dialysate calcium concentration in hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of dialysate calcium concentrations on intradialytic blood pressure course in cardiac-compromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Calcium exposure and removal in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Active vitamin D and acute respiratory infections in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. A 25-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Is the volume of the parathyroid gland a predictor of Maxacalcitol response in advanced secondary hyperparathyroidism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Tumoral calcinosis regression after subtotal parathyroidectomy: a case presentation and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Biochemical aberrations in a dialysis patient following parathyroidectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

New clinical guidelines for selective direct injection therapy of the parathyroid glands in chronic dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effects of percutaneous ethanol injection therapy on subsequent surgical parathyroidectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Plasma osteoprotegerin is associated with mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Histomorphometric measurements of bone turnover, mineralization, and volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Abeta-2M-amyloidosis and related bone diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Recent progress in understanding dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Imaging in dialysis spondyloarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mechanisms of vascular calcification in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Novel insights into vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Determinants of progressive vascular calcification in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Aortic calcification in haemodialysis patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Increased prevalence of significant coronary artery calcification in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Vitamin K-dependent proteins, warfarin, and vascular calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Are peritoneal calcifications in long-term peritoneal dialysis related to aortic calcifications and disturbances in mineral metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Localization and extent of peritoneal calcification in three uremic patients on continuous ambulatory peritoneal dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The impact of diabetes mellitus on vitamin D metabolism in predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Timing of onset of CKD-related metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

FGF23-parathyroid interaction: implications in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum phosphate and mortality in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum phosphate levels and mortality risk among people with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of serum phosphate with vascular and valvular calcification in moderate CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Phosphate binders for preventing and treating bone disease in chronic kidney disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Mechanisms of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Chronic kidney disease, hypovitaminosis D, and mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Vitamin D and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Phosphorus and protein restriction and parathyroid function in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of oral calcitriol with improved survival in nondialyzed CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml/min is a risk factor for falls and fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Renal function and risk of hip and vertebral fractures in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of kidney function with incident hip fracture in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Increased risk of hip fracture among men with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Role of bone biopsy in stages 3 to 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The effect of raloxifene treatment in postmenopausal women with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Parathyroidectomy after successful kidney transplantation: a single centre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Rapid loss of vertebral mineral density after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Can DXA predict fractures in renal transplant patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Use of active vitamin D sterols in patients with chronic kidney disease, stages 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Elevated calcium phosphate product after renal transplantation is a risk factor for graft failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Bisphosphonates and bone fractures in long-term kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The effects of discontinuing cinacalcet at the time of kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effect of teriparatide on early bone loss after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Parathyroid hormone and growth in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Consequences and therapy of the metabolic acidosis of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The bone and mineral disorder of children undergoing chronic peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Sevelamer hydrochloride: an effective phosphate binder in dialyzed children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cinacalcet is efficacious in pediatric dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Middle-term use of Cinacalcet in paediatric dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Cinacalcet does not affect longitudinal growth but increases body weight gain in experimental uraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Slipped capital femoral epiphysis during treatment with recombinant growth hormone for isolated, partial growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effects of Serum Calcium, Phosphorous, and Intact Parathyroid Hormone Levels on Survival in Chronic Hemodialysis Patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1744-9987.12058

21 January 2018

Identifiers

DOI

10.1111/1744-9987.12058

1 reference

23 November 2017

1 reference